Search results

Jump to navigation Jump to search

Page title matches

Page text matches

  • adrenergic beta-antagonist [r]: Drugs {{r|adrenergic beta-antagonist}}
    300 bytes (32 words) - 13:45, 4 July 2009
  • {{main|Adrenergic beta-antagonist}}
    1 KB (159 words) - 04:09, 30 September 2009
  • {{r|Adrenergic beta-antagonist}}
    307 bytes (32 words) - 06:55, 17 October 2010
  • #Redirect [[Adrenergic beta-antagonist]]
    40 bytes (3 words) - 16:07, 6 May 2008
  • #REDIRECT [[Adrenergic beta-antagonist]]
    40 bytes (3 words) - 14:37, 4 January 2011
  • #REDIRECT [[Adrenergic beta-antagonist]]
    40 bytes (3 words) - 10:12, 14 April 2008
  • #REDIRECT [[Adrenergic beta-antagonist]]
    40 bytes (3 words) - 10:12, 14 April 2008
  • #REDIRECT [[Adrenergic beta-antagonist]]
    40 bytes (3 words) - 10:42, 28 June 2008
  • #REDIRECT [[Adrenergic beta-antagonist]]
    40 bytes (3 words) - 10:12, 14 April 2008
  • #REDIRECT [[Adrenergic beta-antagonist]]
    40 bytes (3 words) - 10:10, 14 April 2008
  • #REDIRECT [[Adrenergic beta-antagonist]]
    40 bytes (3 words) - 17:26, 14 April 2008
  • #REDIRECT [[Adrenergic beta-antagonist]]
    40 bytes (3 words) - 17:26, 14 April 2008
  • #Redirect [[Adrenergic beta-antagonist]]
    40 bytes (3 words) - 16:06, 6 May 2008
  • #Redirect [[Adrenergic beta-antagonist]]
    40 bytes (3 words) - 16:07, 6 May 2008
  • #Redirect [[Adrenergic beta-antagonist]]
    40 bytes (3 words) - 16:07, 6 May 2008
  • ...line]], are used to treat [[asthma]] by preventing bronchoconstriction. [[Adrenergic beta-antagonist]]s, such as [[atenolol]] or [[metoprolol]] are used to treat cardiac diseas
    1 KB (147 words) - 06:58, 14 September 2013
  • An [[adrenergic beta-antagonist]] useful in [[angina pectoris]], [[hypertension]], or cardiac [[arrhythmias
    146 bytes (14 words) - 13:31, 4 July 2009
  • A cardioselective [[adrenergic beta-antagonist]] medication for [[hypertension]] and [[angina pectoris]].
    141 bytes (13 words) - 10:15, 21 June 2009
  • {{r|Adrenergic beta-antagonist}}
    638 bytes (62 words) - 07:54, 17 October 2010
  • {{r|Adrenergic beta-antagonist}}
    845 bytes (125 words) - 06:48, 17 October 2010
  • *{{r|Adrenergic beta-antagonist|<math>\beta</math>-blocker}}
    337 bytes (41 words) - 09:07, 19 September 2009
  • {{r|adrenergic beta-antagonist}}
    247 bytes (29 words) - 15:02, 4 July 2009
  • {{r|Adrenergic beta-antagonist}}
    553 bytes (67 words) - 19:16, 11 January 2010
  • {{r|adrenergic beta-antagonist}}
    265 bytes (29 words) - 14:10, 4 July 2009
  • |uses=adrenergic beta-antagonist In [[medicine]], '''bisoprolol''' is a "cardioselective [[adrenergic beta-antagonist|beta-1-adrenergic blocker]]. It is effective in the management of [[hyperte
    2 KB (313 words) - 14:09, 4 July 2009
  • {{r|Adrenergic beta-antagonist}}
    1 KB (165 words) - 08:37, 18 June 2008
  • In [[medicine]], '''propranolol''' is "a widely used non-cardioselective [[adrenergic beta-antagonist|beta-adrenergic antagonist]]. Propranolol has been used for [[myocardial in
    2 KB (236 words) - 14:07, 2 February 2023
  • ...he treatment of [[heart failure]], there is conflicting evidence whether [[adrenergic beta-antagonist]]s are as effective in African-American patients as in Anglo patients.<ref ...inase 2 (GRK2) [[genetic polymorphism]]s may also affect the response to [[adrenergic beta-antagonist]]s.<ref>{{OMIM|109635}}</ref>
    5 KB (679 words) - 09:15, 29 August 2009
  • {{r|Adrenergic beta-antagonist}}
    581 bytes (74 words) - 07:42, 8 January 2010
  • The pharmacogenetics of [[adrenergic beta-antagonist]] medications have been reviewed.<ref name="pmid17542770">{{cite journal |a [[Genetic polymorphism]]s of beta-1 (ADRB1) may affect the response to [[adrenergic beta-antagonist]] treatment of [[heart failure]].<ref>{{OMIM|109630}}</ref>
    6 KB (767 words) - 17:34, 10 February 2024
  • {{r|Adrenergic beta-antagonist}}
    631 bytes (80 words) - 17:07, 11 January 2010
  • ...d [[atenolol]], are used to treat [[hypertension]] and tachyarrythmias. [[Adrenergic beta-antagonist]]s that are selective for the beta-1 adrenergic receptor may be better for [[Genetic polymorphism]]s of the beta-1 receptor may affect responses to [[adrenergic beta-antagonist]]s in the treatment of heart failure<ref>{{OMIM|109630}}</ref> and in preve
    12 KB (1,491 words) - 23:11, 12 October 2011
  • {{r|Adrenergic beta-antagonist}}
    641 bytes (79 words) - 16:44, 11 January 2010
  • {{r|Adrenergic beta-antagonist}}
    2 KB (187 words) - 17:07, 11 January 2010
  • {{r|Adrenergic beta-antagonist}}
    926 bytes (114 words) - 15:48, 11 January 2010
  • {{r|Adrenergic beta-antagonist}}
    1,006 bytes (130 words) - 10:50, 11 January 2010
  • {{r|Adrenergic beta-antagonist}}
    1 KB (134 words) - 15:37, 2 March 2010
  • ...ylation of many drugs and environmental chemicals, such as debrisoquine; [[Adrenergic beta-antagonist|adrenergic receptor antagonist]]s; and [[tricyclic antidepressant]]s. This
    3 KB (483 words) - 17:34, 10 February 2024
  • |properties= adrenergic beta-antagonist In [[medicine]], '''metoprolol''' is a [[adrenergic beta-antagonist]] [[medication]] that is a "selective adrenergic beta-1-blocking agent with
    7 KB (1,032 words) - 13:16, 2 February 2023
  • ...sup> [[randomized controlled trial]]s of perioperative<sup>'''†'''</sup> [[Adrenergic beta-antagonist|beta-blockers]].<ref name="pmid19474688">{{cite journal |author=Dunkelgrun <nowiki>†</nowiki> This table does not include trials that used [[Adrenergic beta-antagonist|beta-blockers]] only for [[premedication]] or only during [[postoperative c
    21 KB (2,642 words) - 17:32, 10 February 2024
  • {{r|Adrenergic beta-antagonist}}
    3 KB (366 words) - 12:22, 18 April 2024
  • In [[medicine]], '''atenolol''' is a cardioselective [[adrenergic beta-antagonist]] that is "possessing properties and potency similar to [[propranolol]], bu ...links&id=18612201 | doi=10.1159/000143389 }} </ref> be better than other [[adrenergic beta-antagonist]]s.
    16 KB (2,243 words) - 11:52, 2 February 2023
  • If the patient is taking a [[Adrenergic beta-antagonist|beta-blocker]], reversing its effect with [[glucagon]] may help if the pati
    12 KB (1,718 words) - 14:14, 21 June 2014
  • [[Adrenergic beta-antagonist]]s may be less effective according to [[meta-analysis|meta-analyses]]<ref n
    4 KB (610 words) - 23:42, 24 May 2012
  • ...links&id=15655528 | doi=10.1038/sj.bjp.0706048 | pmc=PMC1576008 }}</ref> [[Adrenergic beta-antagonist]]s that are selective for the beta-1 [[adrenergic receptor]] may be better ...inase 2 (GRK2) [[genetic polymorphism]]s may also affect the response to [[adrenergic beta-antagonist]]s.<ref>{{OMIM|109635}}</ref>
    36 KB (4,786 words) - 23:10, 12 October 2011
  • [[Randomized controlled trial]]s have found benefit from [[adrenergic beta-antagonist]]s such as [[atenolol]]<ref name="pmid2863754">{{cite journal |author=Kraus A case report shows that [[adrenergic beta-antagonist]]s may remove signs of hyperactivity of the [[sympathetic nervous system]]
    20 KB (2,755 words) - 01:35, 14 September 2013
  • Placebo is as effective as adding the [[adrenergic beta-antagonist]] drug [[propanolol]] to patients not adequately controlled on [[topiramate
    26 KB (3,466 words) - 20:38, 20 March 2014
  • One small study found that while the [[adrenergic beta-antagonist]], [[lisinopril]], lowered resting blood pressure, patients with pets and l
    9 KB (1,385 words) - 08:49, 30 June 2023
  • ...ine]]s of the American College of Cardiology/American Heart Association, [[adrenergic beta-antagonist]]s (beta-blockers, "should begin within a few days of the event, if not ini
    22 KB (2,922 words) - 09:45, 21 February 2015
  • *[[Adrenergic beta-antagonist|ß-blockers]] ...(LVH). Based on these two trials, a [[meta-analysis]] has concluded that [[adrenergic beta-antagonist|beta blockers]] should not be the first choice treatment.<ref name="pmid162
    56 KB (7,418 words) - 15:13, 5 November 2013
  • [[Adrenergic beta-antagonist]]s (beta-blockers) are effective according to a [[systematic review]]<ref n
    27 KB (3,775 words) - 09:26, 5 May 2024
  • | [[Adrenergic beta-antagonist|Beta-blockers]]|| [[Systematic review]]:<ref name="pmid19487713">{{cite jo
    73 KB (10,150 words) - 21:46, 20 August 2014
  • ...has been used to indicate patients who might benefit from perioperative [[adrenergic beta-antagonist|beta-blockers]].<ref name="pmid10588963">{{cite journal |author=Poldermans A [[meta-analysis]] of [[randomized controlled trial]]s found that [[adrenergic beta-antagonist|beta-blockers]] may cause a decrease in [[myocardial ischemia]] ([[number n
    81 KB (10,863 words) - 17:35, 10 February 2024
  • [[Adrenergic beta-antagonist]]s were first shown to be effective in 1981.<ref name="pmid7010157">{{cite
    41 KB (5,532 words) - 23:14, 6 October 2013